Clinical Proteomics in Cancer Research-Promises and Limitations of Current Two-Dimensional Gel Electrophoresis

E-ISSN： 1875-533x|15|23|2393-2400

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.23, 2008-10, pp. : 2393-2400

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Applying Proteomics in Clinical Trials: Assessing the Potential and Practical Limitations in Ovarian Cancer

By Tchabo Nana E. Liel Meghan S. Kohn Elise C.

American Journal of PharmacoGenomics, Vol. 5, Iss. 3, 2005-01 ,pp. : 141-148

Adis International

Access to resources Recommend Favorite

Charge heterogeneity study of a Fc-fusion protein, abatacept, using two-dimensional gel electrophoresis

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 8, 2015-01 ,pp. : 527-534

Govi-Verlag

Access to resources Recommend Favorite

Comparative Proteomics Analysis of SKBR3 and MCF7 Breast Cancer Cell Lines Using Two Dimensional Electrophoresis: Ready to Build Postgenomics Capacity for OMICS R&D in Developing Countries?

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 2, 2012-06 ,pp. : 132-137

Bentham Science Publishers

Access to resources Recommend Favorite

Proteomics in Urological Cancer Research

By Lawrie Laura C. Murray Graeme I.

UroOncology, Vol. 2, Iss. 4, 2002-01 ,pp. : 163-166

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Impact of proteomics on bladder cancer research

By Celis Julio E Gromova Irina Moreira Jose MA Cabezon Teresa Gromov Pavel

Pharmacogenomics, Vol. 5, Iss. 4, 2004-06 ,pp. : 381-394

Future Medicine

Access to resources Recommend Favorite